Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population studyAntonietta Romano, A. Albertí, Paolo Angeli et al.|Journal of Hepatology|2018Cited by 166
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failureElisabetta Degasperi, S. Fagiuoli, Angiola Spinetti et al.|Journal of Hepatology|2019Cited by 92
THU-131-Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto NetworksElisabetta Degasperi, S. Fagiuoli, Angiola Spinetti et al.|Journal of Hepatology|2019Cited by 3
THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from ItalyL. Pasulo, Antonio Albanese, Caterina Uberti‐Foppa et al.|Journal of Hepatology|2019Cited by 1
Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patientsM. Gambato, M.G. Pigozzi, Angiola Spinetti et al.|Digestive and Liver Disease|2019Cited by 1